4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-013944
CHIEF OPERATING OFFICER sold 12,000 shares at $26.41 ($316,920)
- CHIEF OPERATING OFFICER acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-05-19 | Option exercise 10b5-1 | +7,000 | $3.80 | $26,600 | 84,363 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-05-19 | Sale 10b5-1 | −12,000 | $26.41 | $316,920 | 72,363 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-05-19 | Option exercise · Share Option 10b5-1 | −7,000 | 49 | D | ||
| Open-market sales · 12,000 sh · avg $26.41 · $316,920 | |||||||
Loading xslF345X05/form4-05212025_080502.xml…